Company
Headquarters: Taipei, Taiwan
TW$985.7 Million
TWD as of Jan. 1, 2024
US$32.1 Million
Company | Market Cap (USD) |
---|---|
Thermo Fisher Scientific | $207.62 B |
Danaher | $171.89 B |
Siemens Healthineers AG | $66.05 B |
DexCom, Inc. | $46.50 B |
IDEXX Laboratories, Inc. | $44.72 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
Genetics Generation Advancement Corp. provides genetic testing and informatics services in Taiwan, Asia, Europe, and the Americas. The company offers pre-implantation stage, prenatal stage, newborn medical examination, health management, reproductive medicine, obstetrics and gynecology, neonatology and pediatrics, allergy/immunology/rheumatology, gastroenterology and hepatology, oncology, cardiology, and medical research testing services, as well as counseling services for clinicians and patients to identify genetic risks, genetic testing options, interpret the implications of the test results, and help patients make informed healthcare decisions. It also provides bioinformatics and computational life sciences, materials sciences, laboratory informatics, and enterprise quality management system services. The company was formerly known as Genesis Genetics Asia Corp. and changed its name to Genetics Generation Advancement Corp. in February 2016. Genetics Generation Advancement Corp. was founded in 2008 and is based in Taipei City, Taiwan.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Genetics Generation Advancement Corp has the following listings and related stock indices.
Stock: TWSE: 4160 wb_incandescent